Wave Life Sciences

Forecast & Rating21 analysts currently cover Wave Life Sciences, with about 90.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $17.22, about 443.2% upside from the current price of $3.17. Price targets range from $8.37 to $42.00 — a wide spread, showing clear disagreement over just how much Wave Life Sciences can rise. Historically, about 39.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Wave Life Sciences closely still see room for the stock to rise. Data as of Oct 16, 2026; for reference only and not investment advice.